ADLAI NORTYE LTD-ADR (ANL) Stock Fundamental Analysis

NASDAQ:ANL • US00704R1095

9.98 USD
+0.06 (+0.6%)
Last: Feb 23, 2026, 04:04 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

0

ANL gets a fundamental rating of 0 out of 10. The analysis compared the fundamentals against 521 industry peers in the Biotechnology industry. ANL has a bad profitability rating. Also its financial health evaluation is rather negative. ANL does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

  • ANL had negative earnings in the past year.
  • In the past 5 years ANL always reported negative net income.
  • In the past 5 years ANL always reported negative operating cash flow.
ANL Yearly Net Income VS EBIT VS OCF VS FCFANL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 -20M -40M -60M -80M -100M

1.2 Ratios

  • ANL's Return On Assets of -72.00% is on the low side compared to the rest of the industry. ANL is outperformed by 63.53% of its industry peers.
  • ANL's Return On Equity of -654.83% is on the low side compared to the rest of the industry. ANL is outperformed by 77.54% of its industry peers.
Industry RankSector Rank
ROA -72%
ROE -654.83%
ROIC N/A
ROA(3y)-79.22%
ROA(5y)-90.58%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ANL Yearly ROA, ROE, ROICANL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 0 50 -50 -100 -150 -200

1.3 Margins

  • ANL does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ANL Yearly Profit, Operating, Gross MarginsANL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 -20 -40 -60 -80 -100

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

1

2. Health

2.1 Basic Checks

  • ANL has about the same amout of shares outstanding than it did 1 year ago.
  • ANL has a worse debt/assets ratio than last year.
ANL Yearly Shares OutstandingANL Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 10M 20M 30M 40M
ANL Yearly Total Debt VS Total AssetsANL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 100M 200M 300M

2.2 Solvency

  • Based on the Altman-Z score of -7.27, we must say that ANL is in the distress zone and has some risk of bankruptcy.
  • ANL has a Altman-Z score of -7.27. This is in the lower half of the industry: ANL underperforms 66.22% of its industry peers.
  • A Debt/Equity ratio of 5.59 is on the high side and indicates that ANL has dependencies on debt financing.
  • With a Debt to Equity ratio value of 5.59, ANL is not doing good in the industry: 80.81% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 5.59
Debt/FCF N/A
Altman-Z -7.27
ROIC/WACCN/A
WACCN/A
ANL Yearly LT Debt VS Equity VS FCFANL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 0 100M -100M 200M -200M

2.3 Liquidity

  • ANL has a Current Ratio of 1.03. This is a normal value and indicates that ANL is financially healthy and should not expect problems in meeting its short term obligations.
  • ANL's Current ratio of 1.03 is on the low side compared to the rest of the industry. ANL is outperformed by 86.18% of its industry peers.
  • ANL has a Quick Ratio of 1.03. This is a normal value and indicates that ANL is financially healthy and should not expect problems in meeting its short term obligations.
  • With a Quick ratio value of 1.03, ANL is not doing good in the industry: 84.84% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 1.03
Quick Ratio 1.03
ANL Yearly Current Assets VS Current LiabilitesANL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 100M 200M 300M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

0

3. Growth

3.1 Past

  • ANL shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 78.51%, which is quite impressive.
EPS 1Y (TTM)78.51%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%45.7%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • ANL is expected to show a very negative growth in Earnings Per Share. In the coming years, the EPS will decrease by -13.67% yearly.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y69.89%
EPS Next 2Y26.13%
EPS Next 3Y13.3%
EPS Next 5Y-13.67%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ANL Yearly Revenue VS EstimatesANL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2023 2025 2026 2027 2028 2029 2030 2031 2032 100M 200M 300M 400M
ANL Yearly EPS VS EstimatesANL Yearly EPS VS EstimatesYearly EPS VS Estimates 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 1 -1 2 -2

More info and screens

Find the best growth stocksShow best growing peers

0

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for ANL. In the last year negative earnings were reported.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for ANL. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ANL Price Earnings VS Forward Price EarningsANL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ANL Per share dataANL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -0.5 -1

4.3 Compensation for Growth

  • ANL's earnings are expected to grow with 13.30% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y26.13%
EPS Next 3Y13.3%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • No dividends for ANL!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

ADLAI NORTYE LTD-ADR

NASDAQ:ANL (2/23/2026, 4:04:49 PM)

9.98

+0.06 (+0.6%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)10-01
Earnings (Next)N/A
Inst Owners0.05%
Inst Owner Change241.83%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap368.26M
Revenue(TTM)N/A
Net Income(TTM)-51.87M
Analysts76.67
Price Target11.22 (12.42%)
Short Float %7.96%
Short Ratio0.7
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)22.22%
PT rev (3m)22.22%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)26.39%
EPS NY rev (3m)26.39%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 46.49
P/tB 46.66
EV/EBITDA N/A
EPS(TTM)-1.41
EYN/A
EPS(NY)-0.36
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS0
BVpS0.21
TBVpS0.21
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -72%
ROE -654.83%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-79.22%
ROA(5y)-90.58%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-ScoreN/A
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 5.59
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.03
Quick Ratio 1.03
Altman-Z -7.27
F-ScoreN/A
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)50.59%
Cap/Depr(5y)120.9%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)78.51%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%45.7%
EPS Next Y69.89%
EPS Next 2Y26.13%
EPS Next 3Y13.3%
EPS Next 5Y-13.67%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y27.05%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year41.88%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y8.55%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y8.53%
OCF growth 3YN/A
OCF growth 5YN/A

ADLAI NORTYE LTD-ADR / ANL FAQ

What is the ChartMill fundamental rating of ADLAI NORTYE LTD-ADR (ANL) stock?

ChartMill assigns a fundamental rating of 0 / 10 to ANL.


What is the valuation status for ANL stock?

ChartMill assigns a valuation rating of 0 / 10 to ADLAI NORTYE LTD-ADR (ANL). This can be considered as Overvalued.


How profitable is ADLAI NORTYE LTD-ADR (ANL) stock?

ADLAI NORTYE LTD-ADR (ANL) has a profitability rating of 0 / 10.


What is the expected EPS growth for ADLAI NORTYE LTD-ADR (ANL) stock?

The Earnings per Share (EPS) of ADLAI NORTYE LTD-ADR (ANL) is expected to grow by 69.89% in the next year.